US Patent Issued to JAZZ PHARMACEUTICALS IRELAND on March 24 for "Sodium oxybate to treat idiopathic hypersomnia" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,622, issued on March 24, was assigned to JAZZ PHARMACEUTICALS IRELAND Ltd. (Dublin).

"Sodium oxybate to treat idiopathic hypersomnia" was invented by Franck Skobieranda (Palo Alto, Calif.), Dan Chen (Palo Alto, Calif.) and Amanda Leigh Sterkel (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating idiopathic hypersomnia with oxybate, preferably sodium oxybate."

The patent was filed on Oct. 8, 2021, under Application No. 18/248,499.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fn...